HopeStage
Back to all studies
CompletedNCT06733506

Skin antiseptic swabs and safer injection training to prevent infections

About this titleRead the official source — NCT06733506
Medication studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
ChicagoSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 1, 2018
Recruitment status
Completed
Enrollment listed in the registry
56
Sponsor
Gabriel John Culbert
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06733506
Official title
Show the full official title

A Pilot Study to Evaluate the Acceptability and Feasibility of Skin Swabbing With Chlorhexidine Gluconate to Prevent Skin And Soft Tissue Infections Among People Who Inject Drugs

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Chicago

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Gabriel John Culbert.

Did this study involve medication?

Yes. The study involved medication, including Chlorhexidine gluconate and Isopropyl Alcohol 70% Topical Application Solution.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies